About

Baylor Genetics earned an article in GenomeWeb titled “Playing the Long Game: At ACMG, Firms Tout Long-Read Offerings for Rare Disease Testing”  by Huanjia Zhang. This opportunity was secured through SVM’s proactive media outreach surrounding ACMG Annual Meeting 2026, including positioning Baylor Genetics’ latest technology enhancements and poster presentations, and facilitating an interview with Dr. Eng. The coverage highlights Baylor Genetics alongside key competitors, reinforcing your leadership in advancing rare disease diagnostics. Importantly, the article underscores Baylor’s differentiated approach—integrating long-read sequencing and optical genome mapping (OGM) as reflex enhancements to short-read whole-genome sequencing—while emphasizing no additional cost to customers and maintained turnaround times.